A citizens' jury of people with personal experience of hereditary disease has voted in favour of asking the UK government to consider changing the law, to allow for genome editing of human embryos to address serious genetic disorders. In September 2022, 21 people who were either patients with genetic conditions, or relatives or carers of such patients, travelled from across the UK to sit as members of the Citizens' Jury on Human Embryo Editing in the Wellcome Genome Campus near Cambridge.